<DOC>
	<DOC>NCT00824109</DOC>
	<brief_summary>The purpose of this prospective trial is to demonstrate the safety and performance of the Second Generation Anti-Microbial vascular graft in the treatment of aneurysmal and occlusive diseases of the abdominal aorta.</brief_summary>
	<brief_title>Prospective, Multicenter Study of the Second Generation Antimicrobial Graft in the Abdominal Position</brief_title>
	<detailed_description />
	<mesh_term>Anti-Infective Agents</mesh_term>
	<criteria>Is 18 85 years of age Is presenting with an aortoiliac occlusion (obstruction of flow) or stenosis, or aortoiliac aneurysm and is eligible for a revascularization with a bifurcated graft Is affiliated with a social welfare organization system Is willing to participate in the clinical evaluation after signature of the informed consent Is able to attend all follow up visits and diagnostics and laboratory exams required by the present protocol Is treated as an emergency Is included in another investigation Is pregnant or lactating, or a woman of childbearing potential unwillint to use an effective form of contraception for the duration of the trial Has a known allergy to the material device used Has previous aortoiliac bypass or replacement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Aneurysmal disease of the abdominal aorta</keyword>
	<keyword>Occlusive disease of the abdominal aorta</keyword>
</DOC>